MyChart in Patients With Inflammatory Bowel Disease.

NCT03241992 | Completed

• 1 other identifier: H-35695
• Study Type: interventional
• Target: 128
• Locations: 1 country
• Sites: 1

Brief Summary

This study will be the first to assess the use of an electronic health records patient portal for patients with Inflammatory Bowel Disease. Patients with Inflammatory Bowel Disease (IBD), have reduced quality of life, high rates of depression and anxiety, do not receive routine preventative health maintenance (such as vaccines) at the same rate as the general public, and have low adherence to medications. The investigators are seeking to understand whether an electronic health record patient portal (EPIC's MyChart), can be utilized to improve quality of life in this patient population.

Conditions

Inflammatory Bowel Diseases

Keywords

Inflammatory Bowel Disease; IBD; Electronic Health Record; Patient Portal; Quality of Life

Outcome Measures

Primary Outcomes (1)

• Quality of life based on the SIBDQ

  Quality of life will be measured using the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) which is a 10 item health-related quality of life (HRQoL) tool measuring physical, social, and emotional status (scores can range from 10-70, poor to good HRQoL).

  6 months

Secondary Outcomes (4)

• Satisfaction with MyChart

  6-months

• Influenza vaccine uptake

  6-months

• Pneumococcal pneumonia (PCV13, PPSV23) vaccine uptake

  6-months

• Time to Referral for Behavioral Health

  6-months

Study Arms (2)

MyChart Intervention

EXPERIMENTAL

Subjects in the control arm will be enrolled in MyChart during the consent process and receive MyChart Disease Specific targeted IBD information and reminders as well as mood questionnaires. At week 2 subjects will receive reminders to get vaccinated with another reminder sent at 3 months. At month 1, subjects will receive the Promis Adult Short Form questionnaires for depression and anxiety through MyChart. If a subject is identified as having mild, moderate or a severe mood disorder a message will be sent to their gastroenterologist with a recommendation to discuss the results with the patient and to consider a referral to mental health services. Subjects will also receive educational information about IBD every 6 weeks along with reminders to take their medications.

Behavioral: MyChart Disease Specific

Usual Care

NO INTERVENTION

Subjects in the control arm will be enrolled in MyChart during the consent process if they are not previously enrolled. Enrollment in MyChart will provide them with access to their medical record and the ability to send or receive messages with their gastroenterologist or any other providers they see at our institution. For patients with IBD it is standard practice to discuss medication adherence, vaccinations, and their mood at each appointment. Subjects will receive generic, non-IBD related messages through MyChart.

Interventions

MyChart Disease Specific BEHAVIORAL

Subjects receive targeted IBD information and reminders as well as mood questionnaires.

MyChart Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Men and Women 18 years and older with a diagnosis of Inflammatory Bowel Disease (Crohn's or Ulcerative Colitis, or Indeterminate Colitis by standard criteria) who are scheduled for an upcoming appointment at the outpatient gastroenterology clinic or infusion unit.

You may not qualify if:

• Non-English speaking patients
• Patients identified by their physicians as being too cognitively impaired to participate
• Patients without access to computer with internet
• Patients not expected to be in the study area for the duration of the study such as patients only seen for a one time second opinion

Sponsors & Collaborators

• Boston Medical Center: lead

Study Sites (1)

Boston Medical Center

Boston, Massachusetts, 92118, United States

Location

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

Gastroenteritis; Gastrointestinal Diseases; Digestive System Diseases; Intestinal Diseases

Study Officials

• Jason Reich, MD

  Boston Medical Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Fellow, Gastroenterology. General Internal Medicine Department

Study Record Dates

• First Submitted: August 4, 2017
• First Posted: August 8, 2017
• Study Start: November 15, 2017
• Primary Completion: January 20, 2019
• Study Completion: January 20, 2019
• Last Updated: January 28, 2019

Record last verified: 2019-01

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)